Longevity Research9 min read·Published October 2, 2026

What Is a Mitochondrial Mutation? Symptoms, Inheritance, and Testing

A plain-English guide to mtDNA, heteroplasmy, maternal inheritance, mitochondrial disease symptoms, diagnosis, and what longevity research can and cannot prove.

What Is a Mitochondrial Mutation? Symptoms, Inheritance, and Testing

A mitochondrial mutation is a DNA change that can affect how mitochondria make cellular energy. Some mutations are in mitochondrial DNA, which is usually inherited from the mother; others are in nuclear genes that control mitochondria. Effects vary widely, from no symptoms to multi-organ mitochondrial disease requiring specialist evaluation 1.

Wondering if NAD+ is right for you? Take the 3-min clinical quiz.

See if you qualify →

What is a mitochondrial mutation?

A mitochondrial mutation is a change in DNA that affects mitochondria, the parts of the cell that help turn food and oxygen into ATP. ATP is the body’s basic energy currency, and mitochondria are especially important in the brain, muscles, heart, eyes, ears, and endocrine system 1.

Mitochondrial DNA vs nuclear DNA

Most DNA sits in the cell nucleus. A small amount sits inside mitochondria and is called mitochondrial DNA, or mtDNA. Human mtDNA is about 16,500 base pairs long and contains 37 genes: 13 protein-coding genes involved in oxidative phosphorylation, 22 transfer RNA genes, and 2 ribosomal RNA genes 6. For a deeper primer, see our guide to mitochondrial DNA characteristics.

FeatureMitochondrial DNA mutationNuclear DNA mitochondrial disorder
Where the variant isInside mtDNA in mitochondriaInside nuclear genes that help build or maintain mitochondria
Inheritance patternUsually maternal inheritanceMay be autosomal dominant, autosomal recessive, X-linked, or de novo
Typical complexityOften involves heteroplasmy and threshold effectsOften follows Mendelian genetics but can still vary by tissue and severity
Testing approachmtDNA sequencing, deletion testing, tissue-specific testing when neededNuclear gene panels, exome sequencing, or genome sequencing when appropriate

Why mitochondria matter for energy production

Mitochondria contain the mitochondrial respiratory chain, also called oxidative phosphorylation or OXPHOS. This system moves electrons through complexes I through IV and helps make ATP. When an mtDNA or nuclear DNA variant disrupts this system, tissues with high energy demand may be hit hardest 1.

How do mitochondrial mutations cause disease?

Mitochondrial mutations can cause disease when they lower a cell’s ability to make enough ATP for that tissue’s needs. The key ideas are oxidative phosphorylation, heteroplasmy, and the threshold effect 1.

Oxidative phosphorylation and ATP production

OXPHOS uses oxygen and nutrients to help produce ATP. mtDNA encodes several core parts of this system, including subunits of complex I, complex III, complex IV, and complex V. Nuclear DNA encodes many other respiratory-chain and assembly proteins, which is why both mtDNA and nuclear DNA can cause primary mitochondrial disease 1.

Heteroplasmy and the threshold effect

Heteroplasmy means a person has a mix of mutated and non-mutated mtDNA. Symptoms may appear only when the mutation load rises above a tissue’s threshold. A person can also be homoplasmic, meaning most or all mtDNA copies carry the same sequence, but the clinical picture can still vary 1.

This is one reason the same mtDNA mutation can look different in different people, and even in different organs in the same person. A muscle sample, blood sample, or urine sample may not show the same mutation percentage because tissues can carry different levels of mutated mtDNA 5.

What symptoms can mitochondrial mutations cause?

Symptoms can involve almost any organ, but they often show up in high-energy tissues. Five common patterns patients ask about are neurologic, muscle, eye, hearing/vision, and heart-endocrine-gut symptoms 1.

  • Neurologic symptoms: seizures, migraine, ataxia, developmental delay, neuropathy, and stroke-like episodes.
  • Muscle and eye symptoms: ptosis, ophthalmoplegia, chronic progressive external ophthalmoplegia, muscle weakness, and exercise intolerance.
  • Hearing and vision symptoms: sensorineural hearing loss, optic atrophy, and Leber hereditary optic neuropathy.
  • Heart and endocrine symptoms: cardiomyopathy, heart rhythm problems, diabetes, short stature, and thyroid or parathyroid issues.
  • Gastrointestinal symptoms: swallowing problems, poor gut motility, vomiting, constipation, liver involvement, and poor growth in some children.

Symptoms can start in childhood or adulthood. Severe infantile and childhood mitochondrial diseases can be life-threatening, while some adults have milder or more focused symptoms for years before diagnosis 1.

What diseases are linked to mitochondrial DNA mutations?

Several named syndromes are linked to mitochondrial DNA mutations, although many people do not fit neatly into one label. MELAS is one of the better-known mtDNA-related syndromes, and the m.3243A>G mutation is a common cause 1.

ConditionCommon features patients may hear aboutEvidence type
MELASMitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes; often linked with m.3243A>GHuman clinical and genetic evidence
MERRFMyoclonic epilepsy with ragged-red fibers, seizures, ataxia, and muscle findingsHuman clinical and genetic evidence
Leigh syndrome and NARPNeurologic regression, movement problems, neuropathy, ataxia, and retinitis pigmentosa in some formsHuman clinical and genetic evidence
LHONLeber hereditary optic neuropathy, usually presenting with painless central vision lossHuman clinical and genetic evidence
Kearns-Sayre syndrome and CPEOProgressive eye-movement weakness, ptosis, and sometimes heart conduction diseaseHuman clinical and genetic evidence
Pearson syndromeBone marrow dysfunction and pancreatic involvement, usually in early lifeHuman clinical and genetic evidence
Maternally inherited diabetes and deafnessDiabetes plus hearing loss, often linked with m.3243A>GHuman clinical and genetic evidence

Mitochondrial DNA depletion syndrome is a related category in which cells have too little mtDNA, often because of nuclear-gene defects that affect mtDNA maintenance. These disorders show why “mitochondrial disease” is broader than mtDNA alone 1.

Are mitochondrial mutations always inherited from the mother?

No. mtDNA is usually passed from mother to child, but many mitochondrial disorders come from nuclear DNA and can follow autosomal dominant, autosomal recessive, or X-linked inheritance. Maternal inheritance is important, but it is not the whole story 1.

In mtDNA disease, a mother can pass mtDNA variants to children of any sex, but only daughters usually pass mtDNA to the next generation. Because heteroplasmy levels can shift between generations, relatives may have very different symptoms or no symptoms at all 1. For more detail, see our guide to maternal mitochondrial inheritance.

De novo mutations can also occur, meaning the variant appears for the first time in a person. Acquired mtDNA changes may build up in some tissues over time, but those age-related changes are not the same as a diagnosed inherited primary mitochondrial disorder 5.

How are mitochondrial mutations tested and diagnosed?

There is no single simple test for every mitochondrial disorder. Diagnosis often combines genetic testing, symptoms, family history, lab testing, imaging, and sometimes tissue studies 1.

  • Genetic testing may include mtDNA sequencing, mtDNA deletion testing, nuclear mitochondrial gene panels, exome sequencing, or genome sequencing.
  • Blood and urine testing may check lactate, amino acids, organic acids, acylcarnitines, and other markers, but normal results do not always rule out disease.
  • Brain MRI or MR spectroscopy may help when neurologic symptoms are present.
  • Muscle biopsy can show ragged-red fibers, cytochrome c oxidase deficiency, or respiratory-chain enzyme findings in selected cases.
  • A genetic counselor can help explain inheritance, family testing, reproductive options, and what a result does or does not mean.

Referral matters when symptoms are multi-system, progressive, unexplained, or paired with a family pattern. A mitochondrial disease specialist can decide which tissue and test type is most likely to answer the question 1.

What is the life expectancy with mitochondrial mutations?

Life expectancy varies widely. Prognosis depends on the syndrome, mutation, mutation load, organs involved, age of onset, and severity of complications 1.

Some people have mild or adult-onset disease and live for many years with monitoring and supportive care. Severe childhood disease can be life-threatening, especially when the brain, heart, liver, breathing muscles, or feeding are affected 2.

Clinicians often monitor hearing, vision, heart rhythm and structure, endocrine function, nutrition, swallowing, seizures, movement, breathing, exercise tolerance, and growth in children. Monitoring is not just about lifespan; it is also about preventing avoidable complications and improving daily function 1.

Can mitochondrial mutations be treated?

Most primary mitochondrial diseases do not have licensed curative or disease-modifying therapies. Care is usually supportive and individualized, though a small number of specific vitamin, cofactor, biosynthesis, or transporter defects have targeted treatments 2.

Supportive care may include seizure care, heart monitoring, hearing aids, vision support, diabetes care, nutrition, physical therapy, occupational therapy, speech therapy, exercise planning, and avoiding known triggers in selected disorders. These steps are clinician-guided because the right plan depends on the diagnosis and organs involved 1.

Vitamins, antioxidants, and cofactors are widely discussed, but the evidence is mixed and often disorder-specific. Reviews of mitochondrial therapeutics describe ongoing research into redox modulators, mitochondrial biogenesis enhancers, mitophagy-related approaches, nitric oxide precursors, gene-based strategies, mitochondrial replacement approaches, NAD-related agents such as nicotinamide riboside, and investigational drugs including KL1333, idebenone, vatiquinone, and sonlicromanol 2.

At Chia, we talk with patients every day about mitochondrial function, energy, and longevity goals. We offer NAD+ as injection and nasal spray through a licensed-provider evaluation, but NAD+ is not FDA-approved and is not a proven treatment for mitochondrial mutations or primary mitochondrial disease. If you have suspected mitochondrial disease, specialist evaluation and genetic counseling come first.

How does mitochondrial mutation research relate to longevity?

Mitochondria are central to aging biology, but a mitochondrial biomarker is not the same as proven lifespan extension. Human longevity claims need human outcomes, not only cell, animal, or biomarker data.

Human clinical evidence in mitochondrial disease mostly studies symptoms, safety, biomarkers, functional measures, or disease progression. These trials are important, but reviews stress that mitochondrial diseases are rare, diverse, and hard to study with standard trial designs 2.

Human observational evidence can link mtDNA variants, mitochondrial dysfunction, or secondary mitochondrial dysfunction with age-related conditions, but association does not prove cause. Animal and cell evidence can test mechanisms such as reactive oxygen species, mitochondrial biogenesis, and mitophagy, but it cannot prove a person will live longer 5. For a broader view, see our guide to human longevity research and our practical article on how to improve mitochondrial function.

What should you do if you suspect a mitochondrial disorder?

If you suspect a mitochondrial disorder, bring the pattern to a clinician rather than trying to self-diagnose from one symptom or one direct-to-consumer genetic result. Red flags include multi-system symptoms, maternal family patterns, unexplained neurologic events, progressive weakness, vision or hearing loss, or cardiomyopathy with other organ findings 1.

  1. 1Write a three-generation family history, including hearing loss, diabetes, seizures, migraine, stroke-like episodes, vision loss, heart disease, infant deaths, and unexplained neurologic disease.
  2. 2List symptoms by organ system and age of onset.
  3. 3Bring prior labs, imaging, genetic reports, biopsy reports, and medication lists.
  4. 4Ask whether referral to a genetic counselor, neurologist, metabolic specialist, cardiologist, ophthalmologist, or mitochondrial disease clinic is appropriate.
  5. 5Do not assume a direct-to-consumer genetic result confirms or rules out mitochondrial disease; clinical-grade testing may be needed.

If your goal is general mitochondrial health rather than diagnosis, it can help to start with basics that have broad health evidence: sleep, resistance training, aerobic activity, nutrition, and managing metabolic disease. For experimental ideas, our article on mitochondrial repair explains what is promising, what is early, and what remains unproven.

References

  1. 1.Ganetzky RD, Falk MJ. Primary Mitochondrial Disorders Overview. GeneReviews, updated 2024.
  2. 2.Russell OM, Gorman GS, Lightowlers RN, Turnbull DM. Moving towards clinical trials for mitochondrial diseases. Journal of Inherited Metabolic Disease, 2021.
  3. 3.Koenig MK. Drug Development for Rare Mitochondrial Disorders. Neurotherapeutics, 2013.
  4. 4.Kim J, Cheong JH, Kim J. Clinical Approaches for Mitochondrial Diseases. International Journal of Molecular Sciences, 2023.
  5. 5.National Institutes of Health. Mitochondrial DNA Mutations in Heart, Lung and Blood Diseases. NIH Guide, 1996.
  6. 6.MedlinePlus Genetics. Mitochondrial DNA. National Library of Medicine, updated 2025.
  7. 7.TrialX. Natural History Study — Mitochondrial Disease, m.3243A>G mutation listing, 2026.
  8. 8.Cleveland Clinic. Mitochondrial Diseases: Causes, Symptoms and Treatment, 2026.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if NAD+ is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides